A RANDOMIZED PHASE 4 STUDY COMPARING 2 INTRAVENOUS TEMSIROLIMUS (TEMSR) REGIMENS IN SUBJECTS WITH RELAPSED, REFRACTORY MANTLE CELL LYMPHOMA
A RANDOMIZED PHASE 4 STUDY COMPARING 2 INTRAVENOUS TEMSIROLIMUS (TEMSR) REGIMENS IN SUBJECTS WITH RELAPSED, REFRACTORY MANTLE CELL LYMPHOMA
This study will compare the effectiveness and safety of two different doses of temsirolimus (Torisel).
Inclusion Criteria:
Exclusion Criteria:
East Orange, New Jersey 07018, United States
Oklahoma City, Oklahoma 73120, United States
Mainz, 55131, Germany
Kazan', 420029, Russia
Saint Petersburg, 197022, Russia
Saint Petersburg, 197022, Russia